Market Summary
USD252.27-1.17
Market Closed-0.46%
HCA Alerts
HCA Stock Price
HCA RSI Chart
HCA Valuation
HCA Price/Sales (Trailing)
HCA Profitability
HCA Fundamentals
HCA Revenue
HCA Earnings
Price Action
52 Week Range
178.32304.86
(Low)(High)
Last 7 days
-1.6%
Last 30 days
-9.0%
Last 90 days
-14.6%
Trailing 12 Months
30%
HCA Financial Health
HCA Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for HCA
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | 90,000 | cfo and evp |
2023-08-14 | Torres Kathryn A. | sold | -1,400,520 | 269 | -5,204 | svp-payer contracting & align. |
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | -40,500 | cfo and evp |
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | -49,500 | cfo and evp |
2023-08-11 | Cohen Jeffrey E. | sold | -405,000 | 270 | -1,500 | svp-government relations |
2023-08-04 | Marks Mike A | gifted | - | - | -205 | svp-finance |
2023-08-03 | Marks Mike A | gifted | - | - | 8,343 | svp-finance |
2023-08-03 | Marks Mike A | gifted | - | - | -8,343 | svp-finance |
2023-08-03 | Whalen Kathleen M | sold | -787,320 | 270 | -2,916 | svp & chief ethics officer |
2023-08-02 | RUTHERFORD BILL B | gifted | - | - | -49,500 | cfo and evp |
Which funds bought or sold HCA recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | added | 88.67 | 4,828,230 | 9,368,880 | 0.08% |
2023-09-21 | Halpern Financial, Inc. | new | - | 28,831 | 28,831 | 0.01% |
2023-09-20 | BARCLAYS PLC | added | 135 | 85,095,000 | 134,746,000 | 0.09% |
2023-09-20 | Mondrian Investment Partners LTD | reduced | -10.05 | 4,678,210 | 137,307,000 | 2.74% |
2023-09-14 | IMS Capital Management | new | - | 203,332 | 203,332 | 0.11% |
2023-09-12 | Farther Finance Advisors, LLC | added | 2.61 | 14,612 | 95,305 | 0.02% |
2023-09-07 | ST GERMAIN D J CO INC | sold off | - | - | - | -% |
2023-09-05 | Westshore Wealth, LLC | reduced | -6.00 | 40,277 | 532,304 | 0.27% |
2023-09-01 | Manhattan West Asset Management, LLC | reduced | -0.95 | 34,999 | 284,968 | 0.11% |
2023-08-30 | Western Wealth Management, LLC | added | 0.85 | 139,121 | 1,004,830 | 0.09% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
HCA Alerts
Schedule 13G FIlings of HCA Healthcare
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | frist thomas f jr | 24.5% | 69,391,032 | SC 13G/A | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 2.5% | 7,039,050 | SC 13G/A | |
| Feb 14, 2023 | hercules holding ii | 24.4% | 68,912,077 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 6.35% | 17,946,718 | SC 13G/A | |
| Feb 06, 2023 | wellington management group llp | 5.08% | 14,369,349 | SC 13G | |
| Feb 01, 2023 | blackrock inc. | 5.2% | 14,839,215 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 6.7% | 21,128,934 | SC 13G/A | |
| Feb 14, 2022 | hercules holding ii | 22.2% | 68,912,077 | SC 13G/A | |
| Feb 14, 2022 | frist thomas f jr | 22.3% | 69,301,932 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 6.09% | 18,931,643 | SC 13G/A |
Recent SEC filings of HCA Healthcare
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 28, 2023 | S-8 | Employee Benefits Plan | |
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 15, 2023 | 4 | Insider Trading | |
| Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 11, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 07, 2023 | 4 | Insider Trading | |
| Aug 07, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 4 | Insider Trading | |
| Aug 03, 2023 | 4 | Insider Trading |
HCA Fair Value
Loading...
Peers (Alternatives to HCA Healthcare)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
HCA | 68.9B | 61.9B | -8.98% | 30.00% | 11.93 | 1.11 | 3.02% | -11.37% |
LH | 18.2B | 14.1B | -4.55% | -3.42% | 21.91 | 1.29 | -5.68% | -58.27% |
DGX | 13.8B | 9.5B | -7.45% | 1.06% | 17.42 | 1.46 | -10.34% | -46.50% |
| MID-CAP | ||||||||
DVA | 9.0B | 11.7B | -3.28% | 12.82% | 19.26 | 0.77 | 0.96% | -43.93% |
UHS | 8.9B | 13.8B | -2.67% | 35.75% | 12.86 | 0.65 | 5.76% | -10.75% |
EHC | 7.0B | 4.6B | 0.36% | 46.39% | 22.31 | 1.53 | 9.56% | -4.24% |
THC | 6.9B | 19.9B | -9.81% | 26.31% | 6.09 | 0.35 | 3.98% | -22.32% |
SGRY | 3.8B | 2.7B | -12.50% | 20.55% | -69.83 | 1.43 | 11.78% | -86.30% |
SEM | 3.3B | 6.5B | -8.71% | 10.65% | 16.25 | 0.51 | 3.35% | -11.85% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -12.60% | 56.43% | -144.8 | 1.22 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.28% | -6.03% | 25.82 | 1.39 | 10.42% | 21.37% |
BKD | 803.8M | 3.0B | 0.71% | -13.03% | -7.8 | 0.27 | 11.66% | -12.20% |
CYH | 380.3M | 12.4B | -15.50% | 8.59% | 1.34 | 0.03 | -0.02% | 847.37% |
SSY | 6.1M | 46.8M | -7.45% | -15.53% | -2.24 | 0.13 | 12.07% | -154.21% |
HCA Healthcare News
Returns for HCA
Cumulative Returns on HCA
20.3%
10-Year Cumulative Returns
19.4%
7-Year Cumulative Returns
14.4%
5-Year Cumulative Returns
28.6%
3-Year Cumulative Returns
Risks for HCA
What is the probability of a big loss on HCA?
46.5%
Probability that HCA Healthcare stock will be more than 20% underwater in next one year
36.1%
Probability that HCA Healthcare stock will be more than 30% underwater in next one year.
18.5%
Probability that HCA Healthcare stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does HCA drawdown profile look like?
Y-axis is the maximum loss one would have experienced if HCA Healthcare was unfortunately bought at previous high price.
Drawdowns
Financials for HCA Healthcare
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 1.7% | 61,920 | 60,879 | 60,233 | 59,800 | 60,105 | 59,720 | 58,752 | 57,981 | 56,016 | 52,649 | 51,533 | 50,763 | 50,146 | 51,680 | 51,336 | 50,087 | 48,844 | 47,771 | 46,677 | 45,965 | 45,210 |
| EBITDA | -100.0% | - | 13,493 | 13,290 | 12,497 | 13,869 | 14,152 | 14,252 | 13,657 | 11,453 | 10,877 | 9,735 | 9,357 | 9,364 | 9,036 | 9,664 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.22* | 0.22* | 0.21* | 0.23* | 0.24* | 0.24* | 0.24* | 0.20* | 0.21* | 0.19* | 0.18* | 0.19* | 0.17* | 0.19* | - | - | - | - | - | - |
| Interest Expenses | 2.8% | 1,863 | 1,812 | 1,741 | 1,686 | 1,638 | 1,590 | 1,566 | 1,551 | 1,538 | 1,540 | 1,584 | 1,639 | 1,702 | 1,791 | 1,824 | 1,832 | 1,826 | 1,785 | 1,755 | 1,742 | 1,727 |
| Earnings Before Taxes | 0.6% | 8,737 | 8,688 | 8,580 | 7,864 | 9,317 | 9,674 | 9,833 | 9,319 | 7,150 | 6,593 | 5,430 | 4,965 | 4,956 | 4,594 | 5,244 | 5,126 | 5,216 | 5,256 | 5,335 | 5,223 | 4,932 |
| EBT Margin | -100.0% | - | 0.14* | 0.14* | 0.13* | 0.16* | 0.16* | 0.17* | 0.16* | 0.13* | 0.13* | 0.11* | 0.10* | 0.10* | 0.09* | 0.10* | - | - | - | - | - | - |
| Net Income | 0.7% | 5,771 | 5,733 | 5,643 | 5,376 | 6,511 | 6,806 | 6,956 | 6,568 | 4,967 | 4,596 | 3,754 | 3,399 | 3,343 | 3,047 | 3,505 | 3,498 | 3,645 | 3,682 | 3,787 | 3,197 | 2,864 |
| Net Income Margin | -100.0% | - | 0.09* | 0.09* | 0.09* | 0.11* | 0.11* | 0.12* | 0.11* | 0.09* | 0.09* | 0.07* | 0.07* | 0.07* | 0.06* | 0.07* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 4,249 | 4,127 | 4,174 | 3,673 | 4,532 | 5,382 | -200 | 640 | 7,209 | 6,397 | 11,959 | 10,718 | 3,773 | 3,444 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 1.7% | 53,594 | 52,711 | 52,438 | 51,484 | 51,584 | 52,208 | 50,742 | 49,562 | 48,164 | 47,277 | 47,490 | 51,016 | 48,709 | 45,421 | 45,058 | 43,912 | 45,449 | 43,379 | 39,207 | 38,044 | 37,742 |
| Current Assets | 2.6% | 13,888 | 13,541 | 13,643 | 13,481 | 13,937 | 15,006 | 13,542 | 13,248 | 12,475 | 12,036 | 12,333 | 16,266 | 14,031 | 11,016 | 11,196 | 10,769 | 12,869 | 11,108 | 10,213 | 10,010 | 10,394 |
| Cash Equivalents | 2.4% | 862 | 842 | 908 | 999 | 858 | 2,371 | 1,451 | 1,027 | 1,120 | 1,030 | 1,793 | 6,588 | 4,638 | 731 | 621 | 559 | 2,430 | 531 | 502 | 578 | 868 |
| Inventory | -1.7% | 2,050 | 2,085 | 2,068 | 2,009 | 2,043 | 2,003 | 1,986 | 2,019 | 2,027 | 2,068 | 2,025 | 1,950 | 1,834 | 1,953 | 1,849 | 1,769 | 1,826 | 1,778 | 1,732 | 1,634 | 1,636 |
| Net PPE | 2.3% | 26,644 | 26,053 | 25,575 | 24,978 | 24,587 | 24,228 | 24,063 | 23,547 | 23,471 | 23,188 | 23,199 | 22,941 | 23,071 | 22,985 | 22,715 | 22,002 | 21,467 | 21,128 | 19,757 | 19,041 | 18,544 |
| Current Liabilities | 4.7% | 11,545 | 11,028 | 9,902 | 9,784 | 8,999 | 10,518 | 9,582 | 9,624 | 8,615 | 8,642 | 8,704 | 14,379 | 12,856 | 7,019 | 7,757 | 7,124 | 8,961 | 10,531 | 7,569 | 6,231 | 7,625 |
| LT Debt, Current | 0.7% | 2,395 | 2,378 | 370 | 218 | 246 | 1,486 | 237 | 250 | 253 | 234 | 209 | 172 | 163 | 162 | 145 | 148 | 2,073 | 3,796 | 788 | 191 | 1,692 |
| LT Debt, Non Current | 0.2% | 36,537 | 36,478 | 37,714 | 37,492 | 38,657 | 36,210 | 34,342 | 32,049 | 32,319 | 30,838 | 30,795 | 30,792 | 30,779 | 34,699 | 33,577 | 34,097 | 34,120 | 31,019 | 32,033 | 32,916 | 31,500 |
| Shareholder's Equity | 98.7% | 461 | 232 | -73.00 | -778 | -1,142 | 414 | 1,489 | 1,825 | 1,790 | 2,482 | 2,892 | 1,299 | 568 | - | - | - | - | - | - | - | - |
| Retained Earnings | 8.8% | -1,850 | -2,028 | -2,280 | -2,781 | -3,168 | -1,589 | -532 | -206 | -121 | 735 | 777 | -647 | -1,315 | -2,394 | -2,351 | -3,107 | -3,474 | -3,983 | -4,572 | -5,342 | -5,731 |
| Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | 294 | 185 | 88.00 | - | - | - | - | - | - | - | - |
| Accumulated Depreciation | 2.1% | 30,023 | 29,410 | 29,182 | 28,752 | 28,229 | 27,814 | 27,287 | 27,148 | 27,227 | 26,689 | 26,118 | 25,834 | 25,413 | 24,876 | 24,520 | 24,293 | 23,902 | 23,455 | 23,208 | 22,937 | 22,598 |
| Shares Outstanding | -1.1% | 273 | 276 | 277 | 284 | 293 | 302 | 305 | 318 | 328 | 338 | 339 | 338 | 338 | 338 | 338 | 341 | 342 | 343 | 343 | 346 | 349 |
| Minority Interest | 1.4% | 2,764 | 2,727 | 2,694 | 2,592 | 2,538 | 2,447 | 2,422 | 2,520 | 2,383 | 2,235 | 2,320 | 2,273 | 2,354 | 2,259 | 2,243 | 2,118 | 2,132 | 2,099 | 2,032 | 1,875 | 1,864 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 9.4% | 9,825 | 8,980 | 8,522 | 8,438 | 7,695 | 8,316 | 8,959 | 2,933 | 3,373 | 9,845 | 9,232 | 15,320 | 14,729 | 8,003 | 7,602 | 7,272 | 6,867 | 6,452 | 6,761 | 6,320 | 5,607 |
| Share Based Compensation | -8.7% | 303 | 332 | 341 | 357 | 385 | 429 | 440 | 474 | 440 | 377 | 362 | 313 | 337 | 367 | 347 | 327 | 292 | 270 | 268 | 279 | 264 |
| Cashflow From Investing | -1.4% | -3,747 | -3,695 | -3,389 | -4,310 | -3,124 | -2,839 | -2,643 | -1,839 | -3,009 | -2,897 | -3,393 | -3,828 | -4,560 | -4,700 | -5,720 | -5,661 | -5,699 | -5,731 | -3,901 | -3,722 | -4,003 |
| Cashflow From Financing | 10.7% | -6,078 | -6,806 | -5,656 | -4,124 | -4,810 | -4,126 | -6,655 | -6,665 | -3,907 | -6,672 | -4,677 | -5,471 | -7,957 | -3,096 | -1,771 | -1,622 | 403 | -1,248 | -3,075 | -2,727 | -1,435 |
| Dividend Payments | 0.6% | 655 | 651 | 653 | 645 | 636 | 632 | 624 | 476 | 325 | 170 | 153 | 289 | 425 | 561 | 550 | 535 | 520 | 505 | 487 | 488 | 490 |
| Buy Backs | -30.6% | 3,990 | 5,748 | 7,000 | 7,553 | 9,184 | 8,789 | 8,215 | 6,143 | 3,814 | 1,527 | 441 | 713 | 952 | 1,194 | 1,031 | 1,094 | 1,157 | 1,385 | 1,530 | 1,771 | 1,978 |
HCA Income Statement
2023-06-30Condensed Consolidated Income Statements (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenues | $ 15,861 | $ 14,820 | $ 31,452 | $ 29,765 |
| Salaries and benefits | 7,277 | 6,792 | 14,361 | 13,731 |
| Supplies | 2,478 | 2,301 | 4,901 | 4,622 |
| Other operating expenses | 3,043 | 2,693 | 5,937 | 5,445 |
| Equity in losses (earnings) of affiliates | 7 | (8) | 25 | (19) |
| Depreciation and amortization | 763 | 738 | 1,519 | 1,470 |
| Interest expense | 485 | 434 | 964 | 842 |
| Losses (gains) on sales of facilities | (1) | 32 | 14 | 22 |
| Losses on retirement of debt | 0 | 78 | 0 | 78 |
| Total expenses including equity in earnings of affiliates | 14,052 | 13,060 | 27,721 | 26,191 |
| Income before income taxes | 1,809 | 1,760 | 3,731 | 3,574 |
| Provision for income taxes | 397 | 381 | 776 | 730 |
| Net income | 1,412 | 1,379 | 2,955 | 2,844 |
| Net income attributable to noncontrolling interests | 219 | 224 | 399 | 416 |
| Net income attributable to HCA Healthcare, Inc. | $ 1,193 | $ 1,155 | $ 2,556 | $ 2,428 |
| Per share data: | ||||
| Basic earnings | $ 4.35 | $ 3.95 | $ 9.27 | $ 8.16 |
| Diluted earnings | $ 4.29 | $ 3.9 | $ 9.14 | $ 8.05 |
| Shares used in earnings per share calculations (in millions): | ||||
| Basic | 274,494 | 292,527 | 275,695 | 297,459 |
| Diluted | 278,198 | 296,061 | 279,573 | 301,690 |
HCA Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 862 | $ 908 |
| Accounts receivable | 8,713 | 8,891 |
| Inventories | 2,050 | 2,068 |
| Other | 2,263 | 1,776 |
| Total current assets | 13,888 | 13,643 |
| Property and equipment, at cost | 56,667 | 54,757 |
| Accumulated depreciation | (30,023) | (29,182) |
| Property and equipment, net | 26,644 | 25,575 |
| Investments of insurance subsidiaries | 384 | 381 |
| Investments in and advances to affiliates | 731 | 823 |
| Goodwill and other intangible assets | 9,641 | 9,653 |
| Right-of-use operating lease assets | 2,110 | 2,065 |
| Other | 196 | 298 |
| Total assets | 53,594 | 52,438 |
| Current liabilities: | ||
| Accounts payable | 3,823 | 4,239 |
| Accrued salaries | 1,776 | 1,712 |
| Other accrued expenses | 3,551 | 3,581 |
| Long-term debt due within one year | 2,395 | 370 |
| Total current liabilities | 11,545 | 9,902 |
| Long-term debt, less debt issuance costs and discounts of $349 and $301 | 36,537 | 37,714 |
| Professional liability risks | 1,554 | 1,528 |
| Right-of-use operating lease obligations | 1,806 | 1,752 |
| Income taxes and other liabilities | 1,691 | 1,615 |
| Stockholders' equity (deficit): | ||
| Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares - 2023 and 277,378,300 shares - 2022 | 3 | 3 |
| Accumulated other comprehensive loss | (456) | (490) |
| Retained deficit | (1,850) | (2,280) |
| Stockholders' deficit attributable to HCA Healthcare, Inc. | (2,303) | (2,767) |
| Noncontrolling interests | 2,764 | 2,694 |
| Total stockholders' equity | 461 | (73) |
| Total liabilities and stockholders' equity | $ 53,594 | $ 52,438 |
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.